PressDigest

Teva weighs Mylan bid to disrupt Perrigo deal

Teva Pharmaceutical Industries, the Israeli generic drug maker, is weighing a takeover offer for rival Mylan to thwart the latter’s proposed $28.9bn acquisition of Ireland-based Perrigo, The Wall Street Journal has learnt.

WSJ Logo
Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a BillionaireExternal link

Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a Billionaire